PATENT CLAIM ANALYSIS

Application Number: 16064692
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-01
Patent Classification: ["514", "265100"]

Abstract:
Disclosed is an antitumor effect potentiator for one or more other compounds having an antitumor effect, the antitumor effect potentiator comprising a novel pyrrolopyrimidine compound.

Claim (Index 4):
The antitumor effect potentiator according to  claim 1 , wherein, in Formula (A),\n R 1  is a hydroxy group; R 2  is hydrogen or a hydroxy group; R 3  is an ethynylene group, or a monocyclic heteroarylene group having 2 of at least one kind of heteroatom selected from the group consisting of N, S, and O; R 5  is a C3-C7 saturated cycloalkyl group that may have one or more R 6 , a C6-C10 unsaturated cycloalkyl group that may have one or more R 6 , or a monocyclic or bicyclic unsaturated heterocycloalkyl group that has at least one heteroatom selected from the group consisting of N, S, and O, and that may have one or more R 6 ; and R 6  is fluorine; chlorine; a hydroxy group; a cyano group; a C1-C6 alkyl group that may be substituted with one or more phenoxy groups; a carbamoyl group; a C1-C6 alkoxycarbonyl group; a pyridinyl group that may have at least one member selected from the group consisting of halogen, hydroxy group and C1-C4 alkyl group as a substituent; an azetidinyl group; a hydroxyazetidinyl group; a thiomorpholinyl group; a dioxidothiomorpholinyl group; a methylpiperazinyl group; a hydroxypiperidinyl group; an oxopiperidinyl group; a piperidinyl group; a hydroxypyrrolidinyl group; an oxopyrrolidinyl group; a pyrrolidinyl group; a carboxylpyrrolidinyl group; a fluoropyrrolidinyl group; a morpholinyl group; a 9-oxa-3-azabicyclo[3.3.1]nonan-3-yl group; a 3-oxa-8-azabicyclo[3.2.1]octan-8-yl group; an amino group; a methylamino group; an ethylamino group; an isopropylamino group; a hydroxyethylamino group; a dimethylamino group; a phenylmethylamino group; a C1-C6 alkoxy group that may be substituted with one or more of halogen, C3-C7 saturated cycloalkyl group, or monocyclic or bicyclic unsaturated heterocycloalkyl group having at least one heteroatom selected from the group consisting of N, S, and O; a benzyloxy group that may be substituted with one or more carbamoyl groups; a C1-C4 alkylthio group; a C1-C4 alkylsulfonyl group; or an aminosulfonyl group (when a plurality of R 6  are present, the plurality of R 6  may be the same or different).

Metadata:
- Claim Count in Document: 5.0
- Percentile: 94.0
- Lexical Diversity: 1.28571
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15122863', '15890470', '15708917', '15756366', '12310597']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7947220941184231
- 35 USC 102 Novelty (BERT): 0.5858309588673825
- Combined Prediction Score: 0.7738329805933191
- Mean Citation Score: 357.162248
- Max Citation Score: 477.41696
- Similarity Product: 438.2219220669557

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test